Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Valour

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|January 22, 2015
Antimicrobial activity against intraosteoblastic Staphylococcus aureusFlorent Valour, Sophie Trouillet-Assant, Natacha Riffard, et al.
Frontiers in Microbiology|July 28, 2016
Pathophysiological Mechanisms of Staphylococcus Non-aureus Bone and Joint Infection: Interspecies Homogeneity and Specific Behavior of S. pseudintermediusYousef Maali, Patrícia Martins-Simões, Florent Valour, et al.
BMC Infectious Diseases|February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerSandrine Roux, Florent Valour, Judith Karsenty, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2016
Pristinamycin in the treatment of MSSA bone and joint infectionFlorent Valour, André Boibieux, Judith Karsenty, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSACéline Dupieux, Sophie Trouillet-Assant, Caroline Camus, et al.
Journal of Bone and Joint Infection|September 13, 2021
Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infectionsTruong-Thanh Pham, Eugénie Mabrut, Philippe Cochard, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 22, 2024
Mycotic aneurysm due to Magnusiomyces capitatus complicating a second liver transplant in a colonized patientCharles Gibert, Marie Wan, Matthieu Arsicot, et al.
Plos One|July 11, 2013
Staphylococcus epidermidis in orthopedic device infections: the role of bacterial internalization in human osteoblasts and biofilm formationFlorent Valour, Sophie Trouillet-Assant, Jean-Philippe Rasigade, et al.
Open Forum Infectious Diseases|August 2, 2021
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort StudyTristan Ferry, Anne Conrad, Eric Senneville, et al.
BMC Infectious Diseases|November 5, 2016
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administrationOlivier Peeters, Tristan Ferry, Florence Ader, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|January 22, 2015
Antimicrobial activity against intraosteoblastic Staphylococcus aureusFlorent Valour, Sophie Trouillet-Assant, Natacha Riffard, et al.
Frontiers in Microbiology|July 28, 2016
Pathophysiological Mechanisms of Staphylococcus Non-aureus Bone and Joint Infection: Interspecies Homogeneity and Specific Behavior of S. pseudintermediusYousef Maali, Patrícia Martins-Simões, Florent Valour, et al.
BMC Infectious Diseases|February 19, 2016
Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerSandrine Roux, Florent Valour, Judith Karsenty, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2016
Pristinamycin in the treatment of MSSA bone and joint infectionFlorent Valour, André Boibieux, Judith Karsenty, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSACéline Dupieux, Sophie Trouillet-Assant, Caroline Camus, et al.
Journal of Bone and Joint Infection|September 13, 2021
Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infectionsTruong-Thanh Pham, Eugénie Mabrut, Philippe Cochard, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 22, 2024
Mycotic aneurysm due to Magnusiomyces capitatus complicating a second liver transplant in a colonized patientCharles Gibert, Marie Wan, Matthieu Arsicot, et al.
Plos One|July 11, 2013
Staphylococcus epidermidis in orthopedic device infections: the role of bacterial internalization in human osteoblasts and biofilm formationFlorent Valour, Sophie Trouillet-Assant, Jean-Philippe Rasigade, et al.
Open Forum Infectious Diseases|August 2, 2021
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort StudyTristan Ferry, Anne Conrad, Eric Senneville, et al.
BMC Infectious Diseases|November 5, 2016
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administrationOlivier Peeters, Tristan Ferry, Florence Ader, et al.
Pageof 11